Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

3.2K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.2K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.6K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.6K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

5.2K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.2K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

7.2K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
7.2K
Inflammatory Response01:28

Inflammatory Response

15.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
15.0K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

2.5K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interplay of microRNAs and circRNAs in Epithelial Ovarian Cancer.

Non-coding RNA·2024
Same author

Interplay between LncRNAs and microRNAs in Breast Cancer.

International journal of molecular sciences·2023
Same author

Characterization of immunologically detectable T-cell sensitization, Immunohistochemical detection of pro-inflammatory cytokines, and clinical parameters of patients after allogeneic intraoral bone grafting procedures: a prospective randomized controlled clinical trial in humans.

BMC oral health·2022
Same author

The History and Future of Basic and Translational Cell-Free DNA Research at a Glance.

Diagnostics (Basel, Switzerland)·2022
Same author

MicroRNAs and their Implications in CD4+ T-cells, Oligodendrocytes and Dendritic Cells in Multiple Sclerosis Pathogenesis.

Current molecular medicine·2022
Same author

Predictive value of exosomes and their cargo in drug response/resistance of breast cancer patients.

Cancer drug resistance (Alhambra, Calif.)·2022
Same journal

An Optimized RT-qPCR Protocol for Comprehensive Analysis of microRNAs and mRNAs in <i>Mus musculus</i> Brain Tissues.

Non-coding RNA·2026
Same journal

Investigation of Long Non-Coding RNAs <i>H19</i> rs3741219, <i>MEG3</i> rs7158663, <i>POLR2E</i> rs3787016, and <i>ANRIL</i> rs10757274 with Breast Cancer Susceptibility and Clinicopathological Characteristics in a Mexican Population.

Non-coding RNA·2026
Same journal

Comprehensive lincRNA Transcriptome in Acute Myeloid Leukemia: Integrating Known and Newly Identified lincRNAs Across Pediatric and Adult Cohorts.

Non-coding RNA·2026
Same journal

Exploratory Machine Learning Analysis of circRNA-Derived Molecular Features in Autism Spectrum Disorder.

Non-coding RNA·2026
Same journal

Urinary Exosomal microRNAs as a Novel Approach to Study People with Multiple Sclerosis and Severe Gait Disability: A Preliminary Observation.

Non-coding RNA·2026
Same journal

Hnf1aos1 as a Metabolic Coordinator of Hepatic Lipid Homeostasis and Feedback Control.

Non-coding RNA·2026
See all related articles

Related Experiment Video

Updated: Nov 21, 2025

Isolation and Characterization of RNA-Containing Exosomes
09:43

Isolation and Characterization of RNA-Containing Exosomes

Published on: January 9, 2012

100.1K

Exosomes in Immune Regulation.

Heidi Schwarzenbach1,2, Peter B Gahan3

  • 1Department of Gynecology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.

Non-Coding RNA
|January 13, 2021
PubMed
Summary
This summary is machine-generated.

Exosomes, crucial for cell communication, can suppress the immune system in cancer, aiding tumor growth. Researchers are exploring exosome regulation for new cancer immunotherapies.

Keywords:
extracellular vesiclesimmune cellsimmune therapymicroRNAsnon-coding RNAs

More Related Videos

Purification and microRNA Profiling of Exosomes Derived from Blood and Culture Media
10:45

Purification and microRNA Profiling of Exosomes Derived from Blood and Culture Media

Published on: June 14, 2013

32.1K
Isolation and Profiling of MicroRNA-containing Exosomes from Human Bile
06:59

Isolation and Profiling of MicroRNA-containing Exosomes from Human Bile

Published on: June 13, 2016

10.6K

Related Experiment Videos

Last Updated: Nov 21, 2025

Isolation and Characterization of RNA-Containing Exosomes
09:43

Isolation and Characterization of RNA-Containing Exosomes

Published on: January 9, 2012

100.1K
Purification and microRNA Profiling of Exosomes Derived from Blood and Culture Media
10:45

Purification and microRNA Profiling of Exosomes Derived from Blood and Culture Media

Published on: June 14, 2013

32.1K
Isolation and Profiling of MicroRNA-containing Exosomes from Human Bile
06:59

Isolation and Profiling of MicroRNA-containing Exosomes from Human Bile

Published on: June 13, 2016

10.6K

Area of Science:

  • Immunology and Cancer Biology
  • Extracellular Vesicle Research

Background:

  • Exosomes are key mediators of intercellular communication, transferring various biomolecules between cells.
  • While exosomes play protective roles in the immune system, they exhibit immunosuppressive functions in cancer.
  • Tumor-derived exosomes contribute to immune dysregulation and tumor immune escape, promoting cancer progression.

Purpose of the Study:

  • To review the multifaceted role of exosomes in modulating immune cells, including lymphoid and myeloid populations.
  • To explore the potential of exosomes as immunotherapeutic agents for cancer treatment.
  • To discuss strategies for regulating exosome levels for enhanced immunotherapeutic interventions.

Main Methods:

  • Literature review of studies investigating exosome function in cancer immunology.
  • Analysis of exosome cargo and its impact on immune cell behavior.
  • Examination of current research on exosome-based immunotherapies.

Main Results:

  • Exosomes derived from cancer cells possess immunosuppressive properties that hinder anti-tumor immune responses.
  • Exosomes can be engineered or utilized to stimulate specific cytotoxic immune responses against tumors.
  • Modulating exosome production or activity is a promising avenue for cancer immunotherapy.

Conclusions:

  • Exosomes play a dual role in immunity, with tumor-associated exosomes promoting immune evasion.
  • Targeting exosomes offers a novel strategy for developing effective cancer immunotherapies.
  • Further research into exosome biology is critical for advancing cancer treatment.